Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
IBB vs PRHSX
Shared holdings
95
IBB covered by PRHSX
33.09%
PRHSX covered by IBB
33.09%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
IBB (March 31, 2026)
| Security | Weight | |
|---|---|---|
| BlackRock Cash Funds: Institutional, SL Agency Shares | 8.81% | |
| GILEAD SCIENCES INC | 7.06% | |
| AMGEN INC | 6.84% | |
| VERTEX PHARMACEUTICALS INC | 6.79% | |
| REGENERON PHARMACEUTICALS INC | 6.58% | |
| ALNYLAM PHARMACEUTICALS INC | 3.64% | |
| INSMED INC | 2.91% | |
| ARGENX SE SPONSORED ADR | 2.80% | |
| BIOGEN INC | 2.25% | |
| NATERA INC | 2.20% | |
| UNITED THERAPEUTICS CORP DEL | 2.10% | |
| BEONE MEDICINES LTD ADR | 1.76% | |
| INCYTE CORP | 1.55% | |
| MODERNA INC | 1.54% | |
| ILLUMINA INC | 1.53% | |
| REVOLUTION MEDICINES INC | 1.40% | |
| ROIVANT SCIENCES LTD | 1.13% | |
| NEUROCRINE BIOSCIENCES INC | 1.08% | |
| GENMAB A/S -SP ADR DEPOSITARY RECEIPT | 1.07% | |
| BRIDGEBIO PHARMA INC | 1.03% | |
| IONIS PHARMACEUTICALS INC | 1.02% | |
| MEDPACE HOLDINGS INC | 0.92% | |
| MADRIGAL PHARMACEUTICALS INC | 0.91% | |
| EXELIXIS INC | 0.90% | |
| BIOMARIN PHARMACEUTICAL INC | 0.90% | |
| Ascendis Pharma A/S | 0.87% | |
| PRAXIS PRECISION MEDICINES INC | 0.71% | |
| CHARLES RIVER LABS INTL INC | 0.70% | |
| ARROWHEAD PHARMACEUTICALS INC | 0.69% | |
| VAXCYTE INC | 0.68% | |
| BIO-TECHNE CORP | 0.68% | |
| CYTOKINETICS INC | 0.66% | |
| HALOZYME THERAPEUTICS INC | 0.63% | |
| AXSOME THERAPEUTICS INC | 0.61% | |
| BIONTECH SE ADR | 0.60% | |
| KRYSTAL BIOTECH INC | 0.55% | |
| PROTAGONIST THERAPEUTICS INC | 0.53% | |
| REPLIGEN CORP | 0.52% | |
| KYMERA THERAPEUTICS INC | 0.49% | |
| ALKERMES PLC | 0.48% | |
| RHYTHM PHARMACEUTICALS INC | 0.46% | |
| Abivax SA SPONSORED ADS | 0.46% | |
| PTC THERAPEUTICS INC | 0.45% | |
| COGENT BIOSCIENCES INC | 0.44% | |
| ARCELLX INC | 0.43% | |
| TERNS PHARMACEUTICALS INC | 0.42% | |
| NUVALENT INC-A | 0.41% | |
| MIRUM PHARMACEUTICALS INC | 0.41% | |
| TEMPUS AI INC-A | 0.39% | |
| XENON PHARMACEUTICALS INC | 0.39% |
PRHSX (March 31, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 10.14% | |
| THERMO FISHER SCIENTIFIC INC | 4.07% | |
| INTUITIVE SURGICAL INC | 3.65% | |
| STRYKER CORP | 3.46% | |
| MERCK & CO | 3.44% | |
| ASTRAZENECA PLC | 3.17% | |
| UNITEDHEALTH GRP | 3.09% | |
| ARGENX SE SPONSORED ADR | 2.92% | |
| ABBVIE INC | 2.84% | |
| REGENERON PHARMACEUTICALS INC | 2.65% | |
| GILEAD SCIENCES INC | 2.60% | |
| JOHNSON&JOHNSON | 2.44% | |
| VERTEX PHARMACEUTICALS INC | 2.43% | |
| DANAHER CORP | 2.05% | |
| ALNYLAM PHARMACEUTICALS INC | 1.62% | |
| Ascendis Pharma A/S | 1.42% | |
| REVOLUTION MEDICINES INC | 1.36% | |
| UNITED THERAPEUTICS CORP DEL | 1.34% | |
| BEONE MEDICINE-H | 1.19% | |
| ROIVANT SCIENCES LTD | 1.13% | |
| PROTAGONIST THERAPEUTICS INC | 1.11% | |
| INSMED INC | 1.06% | |
| SUMMIT THERAPEUTICS INC | 1.04% | |
| NATERA INC | 1.03% | |
| TENET HEALTHCARE CORP | 1.01% | |
| BRIGHTSPRING HEALTH SERVICES INC | 0.98% | |
| AMGEN INC | 0.98% | |
| BOSTON SCIENTIFIC CORP | 0.92% | |
| HCA HEALTHCARE INC | 0.90% | |
| GUARDANT HEALTH INC | 0.90% | |
| CVS HEALTH CORP | 0.86% | |
| KYMERA THERAPEUTICS INC | 0.77% | |
| THE CIGNA GROUP | 0.74% | |
| CG ONCOLOGY INC | 0.69% | |
| CARDINAL HEALTH INC | 0.68% | |
| ELEVANCE HEALTH INC | 0.66% | |
| KRYSTAL BIOTECH INC | 0.65% | |
| SCHOLAR ROCK HOLDING CORP | 0.62% | |
| IONIS PHARMACEUTICALS INC | 0.61% | |
| BRIDGEBIO PHARMA INC | 0.59% | |
| CHUGAI PHARMA CO | 0.58% | |
| STRUCTURE THERAPEUTICS INC ADR | 0.56% | |
| PRAXIS PRECISION MEDICINES INC | 0.56% | |
| CELCUITY INC | 0.56% | |
| ROYALTY PHARMA PLC | 0.55% | |
| CENCORA INC | 0.52% | |
| CENTESSA PHARMACEUTICALS LTD ADR | 0.50% | |
| VERA THERAPEUTICS INC | 0.46% | |
| NUVALENT INC-A | 0.43% | |
| APOGEE THERAPEUTICS INC | 0.43% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.